Literature DB >> 22467648

Functional recruitment of the human complement inhibitor C4BP to Yersinia pseudotuberculosis outer membrane protein Ail.

Derek K Ho1, Rauna Riva, Vesa Kirjavainen, Hanna Jarva, Erica Ginström, Anna M Blom, Mikael Skurnik, Seppo Meri.   

Abstract

Ail is a 17-kDa chromosomally encoded outer membrane protein that mediates serum resistance (complement resistance) in the pathogenic Yersiniae (Yersinia pestis, Y. enterocolitica, and Y. pseudotuberculosis). In this article, we demonstrate that Y. pseudotuberculosis Ail from strains PB1, 2812/79, and YPIII/pIB1 (serotypes O:1a, O:1b, and O:3, respectively) can bind the inhibitor of the classical and lectin pathways of complement, C4b-binding protein (C4BP). Binding was observed irrespective of serotype tested and independently of YadA, which is the primary C4BP receptor of Y. enterocolitica. Disruption of the ail gene in Y. pseudotuberculosis resulted in loss of C4BP binding. Cofactor assays revealed that bound C4BP is functional, because bound C4BP in the presence of factor I cleaved C4b. In the absence of YadA, Ail conferred serum resistance to strains PB1 and YPIII, whereas serum resistance was observed in strain 2812/79 in the absence of both YadA and Ail, suggesting additional serum resistance factors. Ail from strain YPIII/pIB1 alone can mediate serum resistance and C4BP binding, because its expression in a serum-sensitive laboratory strain of Escherichia coli conferred both of these phenotypes. Using a panel of C4BP mutants, each deficient in a single complement control protein domain, we observed that complement control protein domains 6-8 are important for binding to Ail. Binding of C4BP was unaffected by increasing heparin or salt concentrations, suggesting primarily nonionic interactions. These results indicate that Y. pseudotuberculosis Ail recruits C4BP in a functional manner, facilitating resistance to attack from complement.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467648     DOI: 10.4049/jimmunol.1103149

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway.

Authors:  Mingsong Kang; Ya-Ping Ko; Xiaowen Liang; Caná L Ross; Qing Liu; Barbara E Murray; Magnus Höök
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

2.  Demarcating SurA activities required for outer membrane targeting of Yersinia pseudotuberculosis adhesins.

Authors:  Ikenna R Obi; Matthew S Francis
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

3.  Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection.

Authors:  Michelle K Paczosa; Michael L Fisher; Francisco J Maldonado-Arocho; Joan Mecsas
Journal:  Cell Microbiol       Date:  2013-11-03       Impact factor: 3.715

4.  Ail provides multiple mechanisms of serum resistance to Yersinia pestis.

Authors:  Joshua J Thomson; Sarah C Plecha; Eric S Krukonis
Journal:  Mol Microbiol       Date:  2018-10-26       Impact factor: 3.501

5.  Yersinia pestis targets neutrophils via complement receptor 3.

Authors:  Peter M Merritt; Thomas Nero; Lesley Bohman; Suleyman Felek; Eric S Krukonis; Melanie M Marketon
Journal:  Cell Microbiol       Date:  2014-11-25       Impact factor: 3.715

6.  Defining the Ail Ligand-Binding Surface: Hydrophobic Residues in Two Extracellular Loops Mediate Cell and Extracellular Matrix Binding To Facilitate Yop Delivery.

Authors:  Tiffany M Tsang; Jeffrey S Wiese; Jamal A Alhabeil; Lisa D Usselman; Joshua J Thomson; Rafla Matti; Malte Kronshage; Natalie Maricic; Shanedah Williams; Naama H Sleiman; Suleyman Felek; Eric S Krukonis
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

7.  Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.

Authors:  Bethany L Tiner; Jian Sha; Michelle L Kirtley; Tatiana E Erova; Vsevolod L Popov; Wallace B Baze; Christina J van Lier; Duraisamy Ponnusamy; Jourdan A Andersson; Vladimir L Motin; Sadhana Chauhan; Ashok K Chopra
Journal:  Infect Immun       Date:  2015-01-20       Impact factor: 3.441

Review 8.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

9.  Difficulties in diagnosing terminal ileitis due to Yersinia pseudotuberculosis.

Authors:  H F Wunderink; P M Oostvogel; I H M E Frénay; D W Notermans; A Fruth; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-08       Impact factor: 3.267

10.  Yersinia pseudotuberculosis Exploits CD209 Receptors for Promoting Host Dissemination and Infection.

Authors:  Ying-Xia He; Cheng-Lin Ye; Pei Zhang; Qiao Li; Chae Gyu Park; Kun Yang; Ling-Yu Jiang; Yin Lv; Xiao-Ling Ying; Hong-Hui Ding; Hong-Ping Huang; John Mambwe Tembo; An-Yi Li; Bing Cheng; Shu-Sheng Zhang; Guo-Xing Zheng; Shi-Yun Chen; Wei Li; Lian-Xu Xia; Biao Kan; Xin Wang; Huai-Qi Jing; Rui-Fu Yang; Hua Peng; Yang-Xin Fu; John D Klena; Mikael Skurnik; Tie Chen
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.